Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of ($0.51), $0.06 better than the analyst estimate of ($0.57). Revenue for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE